Attached files
| file | filename |
|---|---|
| 10-K - 10-K - RESMED INC | c819-20210630x10k.htm |
| EX-32.1 - EX-32.1 - RESMED INC | c819-20210630xex32_1.htm |
| EX-31.2 - EX-31.2 - RESMED INC | c819-20210630xex31_2.htm |
| EX-31.1 - EX-31.1 - RESMED INC | c819-20210630xex31_1.htm |
| EX-21.1 - EX-21.1 - RESMED INC | c819-20210630xex21_1.htm |
| EX-10.11 - EX-10.11 - RESMED INC | c819-20210630xex10_11.htm |
| EX-10.10 - EX-10.10 - RESMED INC | c819-20210630xex10_10.htm |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors
ResMed Inc.:
We consent to the incorporation by reference in the registration statements (Nos. 333-08013, 333-88231, 333-115048, 333-140350, 333-140351, 333-156065, 333-164527, 333-167183, 333-181317, 333-186386, 333-194225, 333-224537, 333-245697 and 333-256388) on Form S-8 of our reports dated August 16, 2021, with respect to the consolidated financial statements and financial statement schedule II of ResMed Inc., and the effectiveness of internal control over financial reporting.
Our report on the consolidated financial statements refers to a change in method of accounting for leases due to the adoption of the FASB’s Accounting Standards Codification Topic 842, Leases.
/s/ KPMG LLP
San Diego, California
August 16, 2021